Stay updated on Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.2 to v3.6.3, indicating a minor update to the page version. This update does not change the displayed study information and is likely a backend tweak or small fix.
    Difference
    0.1%
    Check dated 2026-07-03T21:47:12.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Adds a new site revision label 'Revision: v3.6.2' to the page and removes several related topic tags ('Lung cancer', 'related topics:', 'MedlinePlus Genetics') as well as the earlier 'Revision: v3.6.0' tag. This update appears to streamline the page's metadata and navigation by updating the revision reference and pruning older or less relevant topics.
    Difference
    0.3%
    Check dated 2026-06-27T00:22:09.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Added related topics links for Lung cancer and MedlinePlus Genetics to the page; these expand available health-information resources without altering study details.
    Difference
    0.2%
    Check dated 2026-06-19T22:43:58.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The recruitment status is updated to closed, and new guidance links were added to help users read the study record and join a study. Minor UI/content updates include a header label adjustment (Intervention/Treatment), a revision tag, and removal of some related-topic terms.
    Difference
    0.6%
    Check dated 2026-06-12T16:00:45.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.4 to v3.5.5, indicating a minor metadata update. No study data or visible content appears to be affected.
    Difference
    0.1%
    Check dated 2026-06-05T11:59:33.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The related topics header and its entries (Lung cancer and MedlinePlus Genetics) were removed, reducing quick links to disease-related resources on the page.
    Difference
    0.2%
    Check dated 2026-05-29T08:40:11.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page.